US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by OPTIMI HEALTH CORP.

News headline image
Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial
From OPTIMI HEALTH CORP.
Via GlobeNewswire
Tickers CSE:OPTI OPTH
News headline image
Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development
From OPTIMI HEALTH CORP.
Via GlobeNewswire
Tickers CSE:OPTI OPTH
News headline image
Optimi Health Completes Commercial Psilocybin Production to Address Treatment-Resistant Depression in Australia
From OPTIMI HEALTH CORP.
Via GlobeNewswire
Tickers CSE:OPTI OPTH
News headline image
Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia
From OPTIMI HEALTH CORP.
Via GlobeNewswire
Tickers CSE:OPTI OPTH